Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

Auteurs

Paul H. Cottu, Jacques Bonneterre, Andrea Varga, Mario Campone, Alexandra Leary, Anne Floquet, Dominique Berton-Rigaud, Marie-Paule Sablin, Anne Lesoin, Keyvan Rezai, François M. Lokiec, Catherine Lhomme, Jacques Bosq, Alice S. Bexon, Erard M. Gilles, Stefan Proniuk, Veronique Dieras, David M. Jackson, Alexander Zukiwski, Antoine Italiano